Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

People with HIV and low T cell counts have more hair and scalp problems.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Powered exoskeleton training improves body perception and quality of life in spinal cord injury patients.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Pilonidal sinus disease is linked to more severe hidradenitis suppurativa.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Baby teeth stem cells can potentially grow organs and treat diseases.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

The document outlines a method for diagnosing hair loss and suggests specific treatments based on the diagnosis.

Dermoscopy improves diagnosis of hair and scalp disorders and can help avoid unnecessary biopsies.